Chugai Pharma Europe (CPE) is a regional business and wholly owned subsidiary of Tokyo-based Chugai Pharmaceutical Co., Ltd. Established in 1993, the CPE headquarters is based in London, UK, and works with affiliate teams across Europe, including:
Our 200+ people throughout the region make a difference to the lives of patients by contributing to the common mission of the Chugai Group, undertaking activities underpinned by our core values of patient centricity, pioneering spirit and integrity.
As the European hub for the Chugai Group, we support the delivery of our medicines to patients across the region. Collaborating closely with colleagues in our Japanese Headquarters, along with country affiliates from the Chugai Group, we support the research, development, supply, marketing, sales, and safety of our products in our core therapy areas. In addition, we work with a range of existing partners, including Roche and Helsinn, to deliver these functional activities on co-promoted and in-licensed products, or to provide a promotion service. Meanwhile, our innovation and partnering teams actively engage in these therapeutic areas to identify emerging trends and technologies, explore new co-development opportunities, and establish co-beneficial European networks.
With our established presence in Europe, we have teams working across:
Chugai Pharma Europe is part of the Chugai Group and a wholly owned subsidiary of Chugai Pharmaceutical Co., Ltd., one of Japan’s leading research-based pharmaceutical companies. Established in 1925, Chugai Pharmaceutical Co., Ltd. has a 30-year history in biopharmaceuticals and employs over 7,000 specialists.
In 2002, Chugai Pharmaceutical Co., Ltd. entered into a strategic alliance with Roche and since then Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, has been a member of the Roche Group.
C-GB-00000892 | Date of Preparation: November 2023
